Melatonin alleviates oxidative stress and pyroptosis, improves LPS-induced depressive-like behavior, and provides a novel therapeutic approach for depression by inhibiting the activation of the NLRP3 inflammasome in microglia. This evidence concerns the gene NLRP3 and major depressive disorder.